3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
4
Unknown
3
Withdrawn
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
3
Lung Neoplasms
2
Hot Flashes
2
Carcinoma, Non-Small-Cell Lung
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Recurrence
1
Peripheral Nervous System Diseases
1
Febrile Neutropenia
1
Cross Infection
1
Interventions
pembrolizumab
1
enfortumab vedotin
1
Tablets
1
Single Person
1
Rosuvastatin Calcium
1
Memantine
1
Exercise Therapy
1
Exercise
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Peripheral Nervous System Diseases
×
Acupuncture Therapy
×
Clear all
NCT07548476
2026-05-04
ACE
Dana-Farber Cancer Institute
Phase NA
Not yet recruiting
50 enrolled